Improve patient outcomes in wound healing with the best practices of time-honored and cutting-edge approaches.
Robert S Kirsner, MD, PhD, chairman and Harvey Blank Professor at the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery at the University of Miami in Coral Gables, Florida, offered 1 old and 5 new pearls to deliver better outcomes for wound healing in a presentation at Maui Derm for Dermatologists 2022 held January 24 to 28, 2022, in Maui, Hawaii and virtual.1
What to Keep
Use evidence to drive care and stay current with the literature. This old pearl is as pertinent as ever, Kirsner said. While there are many available products on the market for wound healing, dermatologists need to use evidence-based therapies, especially when considering which of the more than 80 cell- and tissue-based products would benefit the individual patient most.1 Examples of those products with evidence include bi-layered cellular products (Apligraf; Organogenesis Inc) for venous leg ulcers (VLU) and diabetic foot ulcers (DFU); acellular products such as porcine (Oasis; Smith+Nephew) for VLU and DFU; cadaveric grafts (GraftJacket; Wright Medical Group) for DFU, and combined shark cartilage and bovine collagen (Omnigraft; Integra) for DFU; and placental agents, such as Epifix (MiMedX) and Grafix (Smith+Nephew) for DFU.1
What to add in 2022
In an interview with Dermatology Times®, Kirsner said, “Often dermatologists don’t think much about wound healing, but dermatologists can leverage the research, tools, and technologies to improve patient outcomes both currently and in the future.” He said dermatologists should be alert to new information as integration of wound healing with the dermatologic procedures know may represent novel ways to address common skin diseases such as skin cancer.